Serdolect FDA Approval Status
FDA Approved: No
Brand name: Serdolect
Generic name: sertindole
Company: Lundbeck A/S
Treatment for: Schizophrenia
Serdolect (sertindole) is an antipsychotic drug for the treatment of schizophrenia without sedative effect and with placebo level extrapyramidal symptoms (EPS).
Development timeline for Serdolect
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
